The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer’s disease: results from a randomized controlled trial

BACKGROUND: Synaptic dysfunction contributes to cognitive impairment in Alzheimer’s disease and may be countered by increased intake of nutrients that target brain phospholipid metabolism. In this study, we explored whether the medical food Souvenaid affects brain phospholipid metabolism in patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Res Ther
Autors principals: Rijpma, Anne, van der Graaf, Marinette, Lansbergen, Marieke M., Meulenbroek, Olga, Cetinyurek-Yavuz, Aysun, Sijben, John W., Heerschap, Arend, Olde Rikkert, Marcel G. M.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530581/
https://ncbi.nlm.nih.gov/pubmed/28747210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0286-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars